Colorado Dog
Oral Melanoma Study in Dogs
RecruitingOral Melanoma
Fully Funded
A fully funded trial to treat canine oral melanoma using a brand new drug over the course of 6 months.
Your vet knows cancer. They may not know about all 156+ active trials.
We search every university research program in the country, find the trials your pet qualifies for, and handle the application on your behalf.
We only feature active trials from accredited universities nationwide.
156+
Active clinical trials tracked
25
Accredited university partners
39
Cancer types covered
Cancers We Cover
Active oncology clinical trials across 39 cancer types. Hover any segment to explore, or see the top conditions in the panel.
Active Enrollment — Top Conditions
Osteosarcoma
40 trials8.2% of covered types
Lymphoma
20 trials4.1% of covered types
Oral Melanoma
20 trials4.1% of covered types
Brain Tumor
19 trials3.9% of covered types
* Some trials cover multiple cancer types and are counted once per type. Total counted (485) may exceed unique trials (156).
Active Clinical Trials
Over 100+ oncology clinical trials are currently underway across the United States. We have highlighted a selection below to illustrate the collaborative opportunities available to you and your pet today.
Oral Melanoma Study in Dogs
How it works
Tell us about your pet
10–15 minutes. Diagnosis, stage, location, and how far you'll travel.
We match against 156+ active trials
Instant results. Every trial at every university checked against your pet's profile simultaneously.
We submit the application for you
No forms to find. No coordinators to cold-call. The research team receives everything and contacts you directly.
Learn more before you search
Your Payment is Secure
256-bit SSL Encryption
Bank-level security on every transaction
Powered by Stripe
Industry-leading payment processor
Payment Info Protected
Payment info never stored on our servers
Stripe is trusted by millions of businesses worldwide, including:
AmazonShopifyGoogleSalesforceInstacart
Latest Resources
Expert insights and guides to help you navigate pet cancer clinical trials
Canine Histiocytic Sarcoma: Breeds at Risk, Treatment, Costs, and Clinical Trials in 2026
Histiocytic sarcoma is an aggressive cancer of the immune system with a strong breed signature — Bernese Mountain Dogs, Flat-Coated Retrievers, Rottweilers, and Golden Retrievers are especially at risk. This guide explains the localized and disseminated forms, what treatment costs, and the clinical trials expanding options in 2026.
By Brycen Levings
Read MoreCanine Bladder Cancer (Transitional Cell / Urothelial Carcinoma): Treatment, Costs, and Clinical Trials in 2026
Transitional cell carcinoma is the most common cancer of the canine urinary tract, and it usually develops in the worst possible spot for surgery. But it's also well understood at the molecular level, giving vets strong diagnostic insight into the disease and a growing list of targeted trial options. Here's what to know in 2026.
By Brycen Levings
Read MoreCanine Soft Tissue Sarcoma: Grades, Surgery, Costs, and Clinical Trials in 2026
"Soft tissue sarcoma" is an umbrella term for a family of connective-tissue tumors that tend to grow locally rather than spread — which makes complete surgery the central challenge and grade the central predictor. This guide explains the tumor types, what treatment costs, and the clinical trials improving local control in 2026.
By Brycen Levings
Read More